Research Title: Efficacy and Safety of Point- Of-care Procalcitonin Test to Reduce Antibiotic Exposure in VAP

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Ventilator Associated Pneumonia
Interventions
DIAGNOSTIC_TEST

PCT-guided group

In the PCT-guided group, the study protocol encourages to stop the prescribed antibiotics if PCT concentration decrease by 80% or more of its peak value (or if PCT concentration is ≥0·25 and \<0·5 μg/L), and strongly encourage to stop the prescribed antibiotics when it reaches a value of \< 0·25 μg/L. The attending physician is free to decide whether to continue antibiotic treatment in patients who reach these thresholds. Reasons for non-adherence will be recorded. Antibiotics in the standard-of-care group will be stopped according to local or national guidelines and according to the discretion of attending physicians. Patients will be followed-up until hospital discharge.

Trial Locations (2)

16150

Mohd Zulfakar Mazlan, MBBS, Kota Bharu

Mohd Zulfakar Mazlan, Kota Bharu

All Listed Sponsors
lead

Mohd Zulfakar Mazlan, MBBS

OTHER

NCT03982667 - Research Title: Efficacy and Safety of Point- Of-care Procalcitonin Test to Reduce Antibiotic Exposure in VAP | Biotech Hunter | Biotech Hunter